<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Clinical manifestations of emerging and neglected zoonoses in non-transplant and transplant population</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead align="center">
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <bold>Pathogen</bold>
    </td>
    <td colspan="2" rowspan="1">
     <bold>Clinical presentation</bold>
     <hr/>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Laboratory diagnosis</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Ref</bold>.
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Immunocompetent patients</bold>
    </td>
    <td rowspan="1" colspan="1">
     <bold>Immunocompromised patients</bold>
    </td>
   </tr>
  </thead>
  <tbody align="center">
   <tr>
    <td colspan="5" align="left" rowspan="1">Vector-borne zoonoses</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Tick-borne encephalitis virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection to severe encephalitis</td>
    <td rowspan="1" colspan="1">Few data: One cluster of fatal TBE</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG), Avidity; VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B14" ref-type="bibr">14</xref>-
     <xref rid="B16" ref-type="bibr">16</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Borrelia burgdorferi</italic>
    </td>
    <td rowspan="1" colspan="1">Erythema migrans, arthritis, peripheral neuropathy, acrodermatitis chronica atrophicans, neuroborreliosis</td>
    <td rowspan="1" colspan="1">Possible dissemination with severe neurological and cardiac symptoms</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); Immunoblot (IgM, IgG); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B18" ref-type="bibr">18</xref>-
     <xref rid="B20" ref-type="bibr">20</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Anaplasma phagocytophilum</italic>
    </td>
    <td rowspan="1" colspan="1">Mostly self-limiting disease, non-specific symptoms, rash, gastrointestinal and CNS involvement</td>
    <td rowspan="1" colspan="1">Unusual presentations: Acute respiratory distress syndrome, haemorrhagic manifestations, pancreatitis, acute renal failure, orchitis</td>
    <td rowspan="1" colspan="1">Microscopy of peripheral blood (morulae); IFA (seroconversion of 4-fold increase in IgG titer); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B26" ref-type="bibr">26</xref>,
     <xref rid="B32" ref-type="bibr">32</xref>,
     <xref rid="B33" ref-type="bibr">33</xref>,
     <xref rid="B43" ref-type="bibr">43</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Ehrlichia</italic> spp.
    </td>
    <td rowspan="1" colspan="1">Self-limiting febrile illness to fatal multi-organ failure</td>
    <td rowspan="1" colspan="1">More frequently severe manifestations: Fatal multiorgan failure, acute respiratory distress syndrome meningoencephalitis, toxic and septic-like syndromes</td>
    <td rowspan="1" colspan="1">Microscopy of peripheral blood (morulae); IFA (seroconversion of 4-fold increase in IgG titer); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B25" ref-type="bibr">25</xref>,
     <xref rid="B36" ref-type="bibr">36</xref>,
     <xref rid="B37" ref-type="bibr">37</xref>,
     <xref rid="B42" ref-type="bibr">42</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Rickettsia</italic> spp.
    </td>
    <td rowspan="1" colspan="1">Self-limiting disease, flu-like symptoms, with or without eschar and rash; vasculitis-mediated organ failure</td>
    <td rowspan="1" colspan="1">Few data: More frequently severe manifestations, splenic rupture</td>
    <td rowspan="1" colspan="1">IFA (IgM, IgG); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B49" ref-type="bibr">49</xref>,
     <xref rid="B51" ref-type="bibr">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Orientia tsutsugamushi</italic>
    </td>
    <td rowspan="1" colspan="1">Nonspecific febrile illness to fatal multiorgan failure, eschar, CNS involvement</td>
    <td rowspan="1" colspan="1">Few data: Only one case with eschar and renal graft dysfunction</td>
    <td rowspan="1" colspan="1">IFA (IgM, IgG); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B53" ref-type="bibr">53</xref>,
     <xref rid="B54" ref-type="bibr">54</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Rift Valley Fever virus</td>
    <td rowspan="1" colspan="1">Subclinical to severe febrile illness, fatal haemorrhagic fever</td>
    <td rowspan="1" colspan="1">Few data: Only one case with meningoencephalitis</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B59" ref-type="bibr">59</xref>,
     <xref rid="B61" ref-type="bibr">61</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">St. Louis encephalitis virus</td>
    <td rowspan="1" colspan="1">Majority asymptomatic, febrile illness, aseptic meningitis and encephalitis</td>
    <td rowspan="1" colspan="1">Few data: Meningoencephalitis</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B63" ref-type="bibr">63</xref>,
     <xref rid="B65" ref-type="bibr">65</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Zika virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection to severe neurological disorders</td>
    <td rowspan="1" colspan="1">Infectious complications and graft rejection</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B69" ref-type="bibr">69</xref>-
     <xref rid="B71" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Chikungunya virus</td>
    <td rowspan="1" colspan="1">Mild febrile illness and polyarthralgia, rarely meningoencephalitis, myocarditis</td>
    <td rowspan="1" colspan="1">No impact on graft function</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B74" ref-type="bibr">74</xref>,
     <xref rid="B75" ref-type="bibr">75</xref>,
     <xref rid="B77" ref-type="bibr">77</xref>,
     <xref rid="B79" ref-type="bibr">79</xref>,
     <xref rid="B80" ref-type="bibr">80</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Dengue virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection to severe fatal illness</td>
    <td rowspan="1" colspan="1">More commonly prolonged course with complications and graft rejection</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; NS1 antigen; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B82" ref-type="bibr">82</xref>,
     <xref rid="B84" ref-type="bibr">84</xref>-
     <xref rid="B86" ref-type="bibr">86</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">West Nile virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection, mild febrile disease, neuroinvasive disease (elderly)</td>
    <td rowspan="1" colspan="1">Fatal neuroinvasive disease more frequent</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; Avidity; VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B87" ref-type="bibr">87</xref>,
     <xref rid="B96" ref-type="bibr">96</xref>,
     <xref rid="B97" ref-type="bibr">97</xref>,
     <xref rid="B108" ref-type="bibr">108</xref>,
     <xref rid="B109" ref-type="bibr">109</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Usutu virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection, neuroinvasive disease (elderly)</td>
    <td rowspan="1" colspan="1">Fatal neuroinvasive disease more frequent</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B114" ref-type="bibr">114</xref>-
     <xref rid="B119" ref-type="bibr">119</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Eastern equine encephalitis virus</td>
    <td rowspan="1" colspan="1">Asymptomatic, neuroinvasive disease (meningitis, encephalitis)</td>
    <td rowspan="1" colspan="1">Few data: Neuroinvasive disease</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B123" ref-type="bibr">123</xref>,
     <xref rid="B124" ref-type="bibr">124</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> spp.
    </td>
    <td rowspan="1" colspan="1">Cutaneous, mucocutaneus and visceral leishmaniasis</td>
    <td rowspan="1" colspan="1">The same as in immunocompetent; organomegaly may be less frequent in visceral leishmaniasis</td>
    <td rowspan="1" colspan="1">Microscopy; Culture; PCR; IFA (IgM, IgG)</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B129" ref-type="bibr">129</xref>,
     <xref rid="B130" ref-type="bibr">130</xref>]
    </td>
   </tr>
   <tr>
    <td colspan="5" align="left" rowspan="1">Non-vector-borne zoonoses</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Hepatitis E virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection, fulminant hepatitis, acute-on-chronic liver failure, extrahepatic manifestations</td>
    <td rowspan="1" colspan="1">Chronic hepatitis, cirrhosis, extrahepatic manifestations</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); Immunoblot (IgM, IgG); RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B131" ref-type="bibr">131</xref>-
     <xref rid="B133" ref-type="bibr">133</xref>,
     <xref rid="B135" ref-type="bibr">135</xref>,
     <xref rid="B136" ref-type="bibr">136</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Rabies virus</td>
    <td rowspan="1" colspan="1">Fatal encephalitis</td>
    <td rowspan="1" colspan="1">Fatal encephalitis</td>
    <td rowspan="1" colspan="1">Microscopy (Negri bodies); DFA (antigen detection); IHC (antigen detection); RT-PCR, RFFIT, FAVN</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B143" ref-type="bibr">143</xref>-
     <xref rid="B146" ref-type="bibr">146</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Lymphocytic choriomeningitis virus</td>
    <td rowspan="1" colspan="1">Asymptomatic infection, nonspecific febrile illness, aseptic meningitis</td>
    <td rowspan="1" colspan="1">More severe clinical presentation, hepatitis, meningoencephalitis, multiorgan failure</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); RT-PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B99" ref-type="bibr">99</xref>,
     <xref rid="B151" ref-type="bibr">151</xref>,
     <xref rid="B152" ref-type="bibr">152</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Toxoplasma gondii</italic>
    </td>
    <td rowspan="1" colspan="1">Asymptomatic, mononucleosis-like symptoms</td>
    <td rowspan="1" colspan="1">More severe clinical presentation, cerebral toxoplasmosis, fatal disseminated disease</td>
    <td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); Avidity, Immunoblot (IgM, IgG); PCR</td>
    <td rowspan="1" colspan="1">[
     <xref rid="B4" ref-type="bibr">4</xref>,
     <xref rid="B156" ref-type="bibr">156</xref>-
     <xref rid="B158" ref-type="bibr">158</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>CNS: Central nervous system; DFA: Direct immunofluorescence assay; ELISA: Enzyme-linked immunosorbent assay; FAVN: Fluorescent antibody virus neutralization test; IFA: Indirect immunofluorescence assay; IgG: Immunoglobulin G; IgM: Immunoglobulin M; IHC: Immunohistochemistry; NS1: Non-structural protein 1; PCR: Polymerase chain reaction; RT-PCR: Reverse-transcriptase polymerase chain reaction; TBE: Tick-borne encephalitis; RFFIT: Rapid fluorescent focus inhibition test; VNT: Virus neutralization test.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
